Showing results (151-160 of 198) with videos related to
Sort By:
Pageof 20
Clinical Nephrology|June 1, 1995
Cholesterol precursor concentration in plasma from patients with chronic renal failure or kidney graftsW H Sutherland, R J Walker, M J Ball, et al.Neurobiology of Aging|July 1, 1995
Cerebral microvessels in Alzheimer's have reduced protein kinase C activityP Grammas, P Moore, T Botchlet, et al.British Journal of Anaesthesia|March 1, 1990
Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolitesC W Hand, J W Sear, J Uppington, et al.Biochemical and Biophysical Research Communications|December 30, 1994
Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase AA E Roher, T C Kasunic, A S Woods, et al.Neurology|June 1, 1988
Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathologyM B Schapiro, M J Ball, C L Grady, et al.European Journal of Clinical Pharmacology|January 1, 1986
Acipimox in the treatment of patients with hyperlipidaemia: a double blind trialM J Ball, M Vella, J P Rechlass, et al.AJNR. American Journal of Neuroradiology|September 1, 1991
Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findingsS M Roman-Goldstein, P A Barnett, C I McCormick, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1993
Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophyS J Kish, Y Robitaille, M el-Awar, et al.Methods of Information in Medicine|January 24, 2008
Failure to provide clinicians useful IT systems: opportunities to leapfrog current technologiesM J Ball, J S Silva, S Bierstock, et al.The New Zealand Medical Journal|September 11, 1991
Blood lipid levels in New ZealandJ I Mann, A Duncan, M J Ball, et al.Pageof 20